Epstein-Barr virus BZLF1 gene promoter variants in pediatric patients with acute infectious mononucleosis: Its comparison with pediatric lymphomas

Journal of Medical Virology

Volumn 81, Issue 11, 2009, Pages 1912-1917

  Lorenzetti, Mario Alejandro ^a   Gutiérrez, Marina Inés ^b   Altcheh, Jaime ^a   Moscatelli, Guillermo ^a   Moroni, Samanta ^a   Chabay, Paola Andrea ^a   Preciado, María Victoria ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b Molecular Biology Division   (Argentina)

Author keywords

BZLF1 variants; Epstein Barr virus; Pediatric infectious mononucleosis; Pediatric lymphoma

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; EPSTEIN BARR VIRUS; FEMALE; GENETIC VARIABILITY; HUMAN; INFECTIOUS MONONUCLEOSIS; LYMPH NODE BIOPSY; LYMPHOMA; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA; MALE; MOLECULAR SEQUENCE DATA; PHARYNX; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS;

HUMAN HERPESVIRUS 4;

EID: 70350445718     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21616     Document Type: Article

References (20)

1. Chabay P, Burna V, Moar A, Grinstein S, Preciado MV. 1999. Prevalencia de la infección ppor el virus de Epstein-Barr en pacientes pediátricos. Rev Hosp De Niños B Aires 41:88-91.
2. Chabay P, De Matteo E, Merediz A, Preciado MV. 2004. High frequency of Epstein-Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina. Arch Virol 149:1515-1526. (Pubitemid 39059505)
3. Chan KH, Tam JSL, Peiris JSM, Seto WH, Ng MH. 2001. Epstein-Barr virus (EBV) infection in infancy. J Clin Virol 21:57-62. (Pubitemid 32194584)
4. Cohen JI. 2000. Epstein-Barr virus infection. N Engl J Med 343:481-492.
5. Correa RM, Fellner MD, Alonio LV, Durand K, Teyssié AR, Picconi MA. 2004. Epstein-Barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latentmembrane protein-1 (LMP-1) oncogene. J Med Virol 73:583-588. (Pubitemid 38857209)
6. Dolan A, Addison C, Gatherer D, Davison AJ, McGeoch DJ. 2006. The genome of Epstein-Barr virus type 2 strain AG876. Virology 350:164-170. (Pubitemid 43850585)
7. Dunne PJ, Faint JM, Gudgeon NH, Fletcher JM, Plunkett FJ, Soares MV, Hislop AD, Annels NE, Rickinson AB, Salmon M, Akbar AN. 2002. Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 100:933-940. (Pubitemid 34832620)
8. Gutierrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, Tsao SW, Yuen PW, Joab I, Margrath IT, Bhatia K. 1997. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus and tumour cells. J Gen Virol 78:1663-1670. (Pubitemid 27343106)
9. Gutierrez MI, Ibrahim MM, Dale JK, Greiner TC, Straus SE, Bhatia K. 2002. Discrete alterations in the BZLF1 promoter in tumor and non-tumor Epstein-Barr virus. J Natl Cancer Inst 94:1757-1763. (Pubitemid 36004352)
10. Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. 2008. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111:1420-1427. (Pubitemid 351213429)
11. Kieff E, Rickinson A. 2006. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, editors. Fields virology, 5th edition. Vol.2. Philadelphia: Lippincott Williams & Wilkins, Inc. pp 2603-2654.
12. Kimura H, Nishikawa K, Hoshino Y, Sofue A, Nishiyama Y, Morishima T. 2000. Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol 188:197-202. (Pubitemid 30411670)
13. Klein E, Kis LL, Klein G. 2007. Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions. Oncogene 26:1297-1305. (Pubitemid 46328467)
14. Martini M, Capello D, Serraino D, Navarra A, Pierconti F, Cenci T, Gaidano G, Larocca LM. 2007. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. J Infect 54:298-306. (Pubitemid 46242050)
15. Ryan JL, Fan H, Swinnen LJ, Schichman SA, Raab-Traub N, Covington M, Elmore S, Gulley ML. 2004. Epstein-Barr virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies. Diagn Mol Pathol 13:61-68. (Pubitemid 38668140)
16. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E. 1990. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64:4084-4092. (Pubitemid 20279813)
17. Speck SH, Chatila T, Flemington E. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol 5:399-405. (Pubitemid 27417826)
18. Tierney RJ, Edwards RH, Sitki-Green D, Croom-Carter D, Roy S, Yao QY, Raab-Traub N, Rickinson AB. 2006. Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: Comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assay. J Infect Dis 193:287-297. (Pubitemid 43113492)
19. Tong JHM, Lo KW, Au FWL, Huang DP, To KF. 2003. Re: Discrete alterations in the BZLF1 promoter in tumor and non-tumor Epstein-Barr virus. J Natl Cancer Inst 95:1008-1009.
20. Yu X, Wang Z, Mertz JE. 2007. ZEB1 Regulates the latent-lytic Switch in Infection by Epstein-Barr virus. PLoS pathog 3:e194.